Abstract
The minimum inhibitory concentrations (MICs) of 24 antibiotics were determined for 45 Stenotrophomonas maltophilia strains by the microdilution method at 37 and 30 °C (after 24 h and 48 h of incubation). The isolates were obtained from mouth swabs and pus of 116 captive snakes whereas the identical strains (based on PFGE) of the same origin were discarded. At 37 °C, the isolates showed a low frequency of resistance to levofloxacin (0 and 8.9 % of resistant strains after 24 and 48 h, MICs50 0.5 and 1 mg/L, MICs90 1 and 2 mg/L) and cotrimoxazole (2.2 % of resistant strains for 24 and 48 h, MICs50 4 mg/L for both time periods, MICs90 4 and 8). At 30 °C, the most effective drugs were also cotrimoxazole (2.2 and 6.7 %, MICs50 4 and 8, MICs90 8 and 32) and levofloxacin (8.9 and 46.7 %, MICs50 1 and 2, MICs90 2 and 4). The isolates were either identically or more susceptible to antibiotics than strains acquired from patients hospitalized at Olomouc University Hospital (the same region) with the exception of ciprofloxacin, cefoperazone, cefoperazone/sulbactam and ceftazidime.
Similar content being viewed by others
Abbreviations
- AMK:
-
amikacin
- AMP:
-
ampicillin
- ATM:
-
aztreonam
- CAZ:
-
ceftazidime
- CFP:
-
cefoperazone
- CFZ:
-
cefazolin
- CHL:
-
chloramphenicol
- CIP:
-
ciprofloxacin
- COL:
-
colistin
- CPS:
-
cefoperazone/sulbactam
- CTX:
-
cefotaxime
- FEP:
-
cefepime
- FOX:
-
cefoxitin
- GEN:
-
gentamicin
- LVX:
-
levofloxacin
- MEM:
-
meropenem
- OFX:
-
ofloxacin
- PIP:
-
piperacillin
- CXM:
-
cefuroxime
- SAM:
-
ampicillin/sulbactam
- SXT:
-
cotrimoxazole
- TET:
-
tetracycline
- TOB:
-
tobramycin
- TZP:
-
piperacillin/tazobactam
References
Berg G., Roskot N., Smalla K.: Genotypic and phenotypic relationships between clinical and environmental isolates of Stenotrophomonas maltophilia. J.Clin.Microbiol.37, 3594–3600 (1999).
Berg G., Eberl L., Hartmann A.: The rhizosphere as a reservoir for opportunistic human pathogenic bacteria. Environ.Microbiol.7, 1673–1685 (2005).
Cérémonie H., Buret F., Simonet P., Vogel T.M.: Isolation of lightning-competent soil bacteria. Appl.Environ.Microbiol.70, 6342–6346 (2004).
CLSI (Clinical and Laboratory Standards Institute): Performance standards for antimicrobial susceptibility testing, 19th informational supplement, M100-S19. Clinical and Laboratory Standards Institute, Wayne (PA, USA) 2009.
Denton M., Kerr K.G.: Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin.Microbiol. Rev.11, 57–80 (1998).
di Bonaventura G., Stepanovic S., Picciani C., Pompilio A., Piccolomini R.: Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia isolates. Folia Microbiol.52, 86–90 (2007).
Draper C.S., Walker R.D., Lawler H.E.: Patterns of oral bacterial infection in captive snakes. J.Am.Vet.Med.Assoc.179, 1223–1226 (1981).
Elting L.S., Khardori N., Bodey G.P., Fainstein V.: Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors. Infect.Control Hosp.Epidemiol.11, 134–138 (1990).
Gould V.C., Okazaki A., Avison M.B.: β-Lactam resistance and β-lactamase expression in clinical Stenotrophomonas maltophilia isolates having defined phylogenetic relationships. J.Antimicrob.Chemother.57, 199–203 (2006).
Hejnar P., Hamal P., Koukalová D.: Influence of an extended incubation period on values of minimum inhibitory concentrations of antibiotics in Stenotrophomonas maltophilia clinical strains. Microbiologica (New Microbiol.)23, 415–421 (2000).
Hejnar P., Kolář M., Hájek V., Koukalová D., Hamal P.: Occurrence of variants with temperature-dependent susceptibility (TDS) to antibiotics among Stenotrophomonas maltophilia clinical strains. Folia Microbiol.46, 151–155 (2001).
Hejnar P., Chmela Z., Rypka M.: Fatty acid analysis of Stenotrophomonas maltophilia clinical strains showing different susceptibility to antibiotics at 30 and 37 °C. Folia Microbiol. 47, 742–746 (2002).
Hejnar P., Bardoň J., Sauer P., Kolář M.: Stenotrophomonas maltophilia as a part of normal oral bacterial flora in captive snakes and its susceptibility to antibiotics. Vet.Microbiol.121, 357–362 (2007).
Khardori N., Elting L., Wong E., Schable B., Bodey G.P.: Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev.Infect.Dis.12, 997–1003 (1990).
Mary P., Defives C., Hornez J.P.: Occurrence and multiple antibiotic resistance profiles of non-fermentative Gram-negative microflora in five brands of non-carbonated French bottled spring water. Microb.Ecol.39, 322–329 (2000).
Pankuch G.A., Jacobs M.R., Rittenhouse S.F., Appelbaum P.C.: Susceptibilities of 123 strains of Xanthomonas maltophilia to eight β-lactams (including β-lactam-β-lactamase inhibitor combinations) and ciprofloxacin tested by five methods. Antimicrob. Agents Chemother.38, 2317–2322 (1994).
Papapetropoulou M., Iliopoulou J., Rodopoulou G., Detorakis J., Paniara O.: Occurrence and antibiotic resistance of Pseudomonas species isolated from drinking water in southern Greece. J.Chemother.6, 111–116 (1994).
Wilkinson F.H., Kerr K.G.: Bottled water as a source of multi-resistant Stenotrophomonas and Pseudomonas species for neutropenic patients. Eur.J.Cancer Care7, 12–14 (1998).
Wüst J., Frei R., Gunthard H., Altwegg M.: Analysis of restriction fragment length polymorphism and ribotyping of multiresistant Stenotrophomonas maltophilia isolated from persisting lung infection in a cystic fibrosis patient. Scand.J.Infect.Dis.27, 499–502 (1995).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hejnar, P., Kolář, M. & Sauer, P. Antibiotic resistance of Stenotrophomonas maltophilia strains isolated from captive snakes. Folia Microbiol 55, 83–87 (2010). https://doi.org/10.1007/s12223-010-0014-9
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-010-0014-9